Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...

Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive global trial has found that a combination of two medications, enzalutamide ...

Joe Biden has been diagnosed with an "aggressive form" of prostate cancer. Biden’s team shared a statement on Sunday that the former president was experiencing "increasing urinary symptoms" ahead of ...

While prognoses for prostate cancer patients were once measured in months, experts say that advances in treatment and diagnosis now improve survival by years. By Gina Kolata Prostate cancer experts ...

A treatment paradox has recently come to light in prostate cancer: blocking testosterone production halts tumor growth in early disease, while elevating the hormone can delay disease progression in ...

ArteraAI Prostate is now an FDA-regulated software (as a medical device) to estimate long-term outcomes and predict the benefit of hormone therapy for individual patients with localized prostate ...

Fig 1. Summary of germline and somatic genomic testing for metastatic prostate cancer recommendations. ARPI, androgen receptor pathway inhibitor; CRPC, castration-resistant prostate cancer; CSPC, ...

Please provide your email address to receive an email when new articles are posted on . A genetic test that identifies the PAM50 biomarker predicted which patients with recurrent prostate cancer would ...